255 related articles for article (PubMed ID: 21124081)
41. Wegener's granulomatosis--a diagnostic challenge.
Holc I; Pahor A; Krajnc I
Wien Klin Wochenschr; 2000 Aug; 112(15-16):680-3. PubMed ID: 11020956
[TBL] [Abstract][Full Text] [Related]
42. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
[TBL] [Abstract][Full Text] [Related]
43. [Granulomatous meningitis, crescentic glomerulonephritis and vasculitis].
Ludueña A; Dorado E; Sarano J; Semeniuk G
Medicina (B Aires); 2011; 71(4):369-72. PubMed ID: 21893452
[TBL] [Abstract][Full Text] [Related]
44. Non-healing granuloma and the nervous system.
Anderson JM; Jamieson DG; Jefferson JM
Q J Med; 1975 Apr; 44(174):309-23. PubMed ID: 170638
[TBL] [Abstract][Full Text] [Related]
45. Pathogenesis of Wegener's granulomatosis: current concepts.
Sarraf P; Sneller MC
Expert Rev Mol Med; 2005 May; 7(8):1-19. PubMed ID: 15890083
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
47. [Ear, nose and throat manifestations of Wegener's granulomatosis (granulomatosis with polyangiitis)].
Morales-Angulo C; García-Zornoza R; Obeso-Agüera S; Calvo-Alén J; González-Gay MA
Acta Otorrinolaringol Esp; 2012; 63(3):206-11. PubMed ID: 22439922
[TBL] [Abstract][Full Text] [Related]
48. [Recent clinicopathophysiological status and treatment in Wegener's granulomatosis].
Yoshida M
Nihon Rinsho; 2005 May; 63 Suppl 5():323-9. PubMed ID: 15954370
[No Abstract] [Full Text] [Related]
49. [Wegener's granulomatosis: Pathogenesis, pathophysiology, and therapy].
Yoshida M
Nihon Rinsho; 2006 Feb; 64 Suppl 2():460-6. PubMed ID: 16523934
[No Abstract] [Full Text] [Related]
50. [A case of early recognized Wegener's granulomatosis with renal involvement. Insights for early diagnosis].
Matuszewska A; Misterska-Skóra M; Wiland P
Ann Acad Med Stetin; 2010; 56(1):41-4; discussion 44. PubMed ID: 21427813
[TBL] [Abstract][Full Text] [Related]
51. A patient with Wegener's granulomatosis presenting with a subarachnoid hemorrhage: case report and review of CNS disease associated with Wegener's granulomatosis.
Cruz DN; Segal AS
Am J Nephrol; 1997; 17(2):181-6. PubMed ID: 9096451
[TBL] [Abstract][Full Text] [Related]
52. Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment.
Almouhawis HA; Leao JC; Fedele S; Porter SR
J Oral Pathol Med; 2013 Aug; 42(7):507-16. PubMed ID: 23301777
[TBL] [Abstract][Full Text] [Related]
53. Wegener's granulomatosis confined to nervous system.
Lucchetta M; Favero M; Schiavon F; Cagnin A; Manara R; Rotilio A; Orvieto E; Giannini C; Briani C
BMJ Case Rep; 2008; 2008():bcr0620080283. PubMed ID: 21716820
[TBL] [Abstract][Full Text] [Related]
54. Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease.
Tarabishy AB; Schulte M; Papaliodis GN; Hoffman GS
Surv Ophthalmol; 2010; 55(5):429-44. PubMed ID: 20638092
[TBL] [Abstract][Full Text] [Related]
55. Renal & ocular targets for therapy in Wegener's granulomatosis.
Joshi L; Hamour S; Salama AD; Pusey CD; Lightman S; Taylor SR
Inflamm Allergy Drug Targets; 2009 Mar; 8(1):70-9. PubMed ID: 19275695
[TBL] [Abstract][Full Text] [Related]
56. Ischemic stroke as a presenting feature of Wegener's granulomatosis.
Jethava A; Ali S
Conn Med; 2013 Oct; 77(9):533-5. PubMed ID: 24266130
[TBL] [Abstract][Full Text] [Related]
57. Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide.
Benucci M; Li Gobbi F; Panconesi P; Manfredi M; Sarzi-Puttini P; Atzeni F
Reumatismo; 2013 May; 65(2):90-4. PubMed ID: 23877415
[TBL] [Abstract][Full Text] [Related]
58. Granulomatosis with polyangiitis (Wegener's granulomatosis) in children: report of three cases with cutaneous manifestations and literature review.
Gajic-Veljic M; Nikolic M; Peco-Antic A; Bogdanovic R; Andrejevic S; Bonaci-Nikolic B
Pediatr Dermatol; 2013; 30(4):e37-42. PubMed ID: 23145989
[TBL] [Abstract][Full Text] [Related]
59. Clinical manifestations and treatment of Wegener's granulomatosis.
Holle JU; Laudien M; Gross WL
Rheum Dis Clin North Am; 2010 Aug; 36(3):507-26. PubMed ID: 20688247
[TBL] [Abstract][Full Text] [Related]
60. Electrodiagnostic characteristics of Wegener's granulomatosis-associated peripheral neuropathy.
Jimenez-Medina HJ; Yablon SA
Am J Phys Med Rehabil; 1992 Feb; 71(1):6-11. PubMed ID: 1310860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
